Aktie 857675 BECTON, DICKINSON AND COMPANY
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Becton, Dickinson and Company Swiss Exchange

Aktien

857675

US0758871091

BDX

Markt geschlossen - Swiss Exchange
Andere Börsenplätze
 17:35:20 28.06.2019 		% 5 Tage % 1. Jan.
243,4 CHF +0,72 % Intraday Chart für Becton, Dickinson and Company -.--% -.--%
26.06. BD (Becton, Dickinson and Company) kündigt die Markteinführung eines neuen Einzelzell-Forschungstools an CI
20.06. Tandem Diabetes Care, Inc. ernennt Jean-Claude Kyrillos zum Executive Vice President und Chief Operating Officer mit Wirkung vom 21. Juni 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
BD to Announce Financial Results for its Third Quarter of Fiscal 2024
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
Becton Dickinson and : BD Issues Annual Product Security Report, Highlighting Transparency and Collaboration
Sector Update: Health Care Stocks Steady Premarket Monday
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.
EE.UU. - Valores a seguir en Wall Street (actualizado)
Becton Dickinson and : Rima Alameddine Named President of BD Peripheral Intervention
Exclusive-Biden to put tariffs on China medical supplies - sources
Becton Dickinson and : BD, City of Hope to Offer Pharmacy Residency Program for Medication-Use Safety and Policy
Sector Update: Health Care Stocks Mixed Premarket Thursday
Sector Update: Health Care
Becton Dickinson and : Earnings Release Q2 FY24
Becton, Dickinson's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 857675 Aktie
  4. 857675 Aktie
  5. Nachrichten Becton, Dickinson and Company
  6. Andere Sprachen